Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Related Topics
Stock news
Merck (MRK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MADISON, N.J., January 26, 2023--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and Drug Administration’s approval of an expanded indication for BRAVECTO® Chews for Dogs. The new indication treats and controls Asian longhorned ticks, which are an invasive Ixodid species located across more than one-third of the U.S1,2.
RAHWAY, N.J., January 25, 2023--Merck Announces KEYNOTE-991 Trial of KEYTRUDA Plus Enzalutamide and Androgen Deprivation Therapy in Patients With mHSPC to Stop for Futility
RAHWAY, N.J., January 25, 2023--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive results from the Phase 3 KEYNOTE-966 trial. In the final analysis of this trial, KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with standard of care chemotherapy (gemcitabine and cisplatin) demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS) versus chemotherapy alone for the first-line treatment of patients wit
RAHWAY, N.J., January 24, 2023--Merck Announces Second-Quarter 2023 Dividend
Smead Capital Management, an investment management company, released its “Smead Value Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. In the fourth quarter, the fund delivered 13.72% compared to a 7.56% gain for the S&P 500 Index and a 12.42% rise for the Russell 1000 Value Index. However, […]
Sinopharm said on Friday its biotech unit has received regulatory approval for clinical trials of its mRNA COVID-19 vaccine targeting the Omicron variant. The unit, based in the commercial hub of Shanghai, has built a research and development platform, as well as workshops with annual production capacity of 2 billion doses of mRNA vaccine, Sinopharm said. Sinopharm, now the China distributor of Merck & Co's COVID-19 antiviral treatment molnupiravir, said its biotech unit received clinical tria...
Perceiv AI announced that the company has been selected by Merck (NYSE: MRK) for the inaugural Merck Digital Sciences Studio (MDSS) cohort, along with eight other early-stage biomedical startups from a pool of 152 applicants. The program started in November to fuel innovative digital technologies for drug discovery and development.
Merck & Co has discovered how its blockbuster diabetes drugs have become contaminated with a potential carcinogen and believes it can resolve the problem by the end of the year, Bloomberg News reported on Tuesday. The company submitted a report to the U.S. Food and Drug Administration (FDA) and other regulators after identifying the root cause for the presence of a nitrosamine called NTTP in certain batches of the drugs, according to the report, which cited a person familiar with the situation....
In this article, we discuss 12 best DRIP stocks to own. You can skip our detailed analysis of dividend reinvestments and their returns over the years, and go directly to read 5 Best DRIP Stocks To Own. A dividend reinvestment plan, or DRIP, is an investment strategy through which investors reinvest their cash dividends into […]